Of patients in the solifenacin 5 mg group, 48% elected a dose increase, and 51% of patients in the tolterodine ER group elected a dose increase at four weeks.

Additionally, 24% of 505 patientstreated with tolterodine ER 4 mg once dailyreported dry mouth compared with 8% of507 patients who received placebo. 25,26 Severe dry mouth occurred in only 1% to 5 ...

Thermo Fisher Scientific has announced two new ion chromatography (IC) methods designed to reduce time and labor and increase accuracy when determining tartrate in drug products containing tolterodine ...